Frank Rimerman Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procept Biorobotics
PRCT
|
+$29.5M |
| 2 |
SentinelOne
S
|
+$7.84M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
+$7.16M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$6.64M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$4.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$9M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.52M |
| 3 |
iShares Micro-Cap ETF
IWC
|
+$2.47M |
| 4 |
iShares Select U.S. REIT ETF
ICF
|
+$1.68M |
| 5 |
Visa
V
|
+$1.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 11.21% |
| 2 | Healthcare | 10.93% |
| 3 | Technology | 9.34% |
| 4 | Financials | 0.88% |
| 5 | Consumer Discretionary | 0.7% |
Similar funds
Frank Rimerman Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Frank Rimerman Advisors held 131 positions worth $262M, down 16% from $312M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Frank Rimerman Advisors deployed $14.9M of net new capital in Q2 2022, opening 10 new positions and adding to 17 existing holdings. Its largest new stake was Procept Biorobotics: 811,623 shares worth $26.5M.
By sector, the portfolio is most concentrated in Communication Services at 11% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $9M trimmed.
- Frank Rimerman Advisors's largest Q2 2022 buy was Procept Biorobotics: 811,623 shares worth $26.5M.
- Frank Rimerman Advisors added most to SentinelOne in Q2 2022, an estimated $7.84M increase.
- Frank Rimerman Advisors's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $9M.
- Frank Rimerman Advisors fully exited Visa in Q2 2022, selling an estimated $1.31M.
- Frank Rimerman Advisors's ten largest holdings make up 66% of its $262M portfolio in Q2 2022.
- Frank Rimerman Advisors opened 10 new positions and closed 44 in Q2 2022.
- Frank Rimerman Advisors's portfolio value fell 16% quarter-over-quarter to $262M.
Based on Frank Rimerman Advisors's 13F filing for Q2 2022, filed 7 Sep 2023.